Delivery Order SPE2DB22D1106-SPE2DB24FEHN2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The $2,949.00 fixed-price contract has a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of INFANRIX DTAP SYRINGE 0.5ML. The fixed-price, firm-fixed-price contract has a ceiling value of $1,082.06 and a period of performance through March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,036.15 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, with a potential value of $1,447.30. The contract has a completion date of December 22, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies to support DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Infanrix DTAP syringes (0.5 mL) with a ceiling value of $7,231.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion by September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INFANRIX DTAP SYRINGE 0.5ML vaccines. This $1,204.90 contract has a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor for this order, which is a child contract under a potential $999,999,999.00 indefinite delivery contract (IDC) the company holds with DLA to supply...
- This federal contract award is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,769.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant indefinite delivery contract (IDC) with the DLA Troop Support Medical valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Infanrix DTAP Syringe 0.5ML, a pediatric vaccine product, with a contract value of $1,391.22. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,949.00 firm-fixed-price delivery order contract covers the supply of INFANRIX DTAP SYRINGE 0.5ML medical products. The contract has an ultimate completion date of August 21, 2024. While the original solicitation was not provided, the contract appears to be part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHN2Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the provision of INFANRIX DTAP SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of March 29, 2024 and a ceiling value of $2,229.00. AmerisourceBergen Drug Corp is the prime contractor and this delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp by DLA, with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/28/24 |